Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
NCT00151203
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Clarithromycin, Lenalidomide, Dexamethasone
Sponsor
Weill Medical College of Cornell University
Collaborators
[object Object]